APP下载

新型吡唑啉酮-六氢山酮素-氧化吲哚衍生物的合成

2020-02-24姜维艳刘雄利邓国栋

合成化学 2020年1期
关键词:吡唑吲哚产率

姜维艳, 岳 静, 刘雄利, 邓国栋*

(1. 贵州装备制造职业学院,贵州 贵阳 550025;2. 贵州大学 贵州省药食同源植物资源开发工程技术研究中心,贵州 贵阳 550025)

把两个或多个有生物活性的骨架拼接成具有潜在生物活性的多骨架分子,是重要的新化合物构造策略[1-2]。六氢山酮素骨架在广泛存在于药物和天然产物分子中。如天然产物分子Diversonol, Desoxydiversonol, Ergochrome DD和Isocochlioquinone A共有一个六氢山酮素骨架单元,这类化合物具有良好的镇痛作用[3-5]。螺六元碳环氧化吲哚主要存在于天然产物和合成药物分子中[6-8],如天然产物分子Satavaptan表现出明显的生物活性。螺环吡唑啉酮是重要的天然产物和药物分子[9-11],在生物制药领域有重要应用价值。因此,将螺环吡唑啉酮和六氢山酮素骨架拼接到螺环氧化吲哚骨架上,有望合成一系列具有多样性特征的新化合物,为生物活性筛选提供化合物源。目前合成六氢山酮素骨架的方法主要为:以3-吸电子基团的色酮为起始原料[12-14],经4+2环加成反应合成,反应存在底物局限性。

Scheme 1

本文以色酮-吡唑啉酮合成子(1)与3-烯键氧化吲哚(2)[15]为原料,DABCO为催化剂,氯仿为溶剂,于室温发生分子间Michael加成反应后再发生分子内环化反应,合成了14个新型的吡唑啉酮六氢山酮素骨架拼接氧化吲哚3a~3n,产率75%~89%,dr值7/1~11/1,其结构经1H NMR,13C NMR和HR-MS(ESI-TOF)表征。

1 实验部分

1.1 仪器与试剂

WRS-1B型数字熔点仪;Bruker-500 MHz型核磁共振仪(CDCl3为溶剂,TMS为内标);MicroTMQ-TOF型高分辨质谱仪。

所用试剂均为分析纯。

1.2 3a~3n的合成(以3a为例)

在反应管中依次加入吡唑啉酮-色酮合成子(1a)66.4 mg(0.20 mmol), 3-烯键氧化吲哚(2a)8.03 mg(0.25 mmol), 10 mol%DABCO 2.24 mg(0.02 mmol)和氯仿2.0 mL,搅拌下于室温反应约3 d(TLC检测)。经硅胶柱层析[洗脱剂:V(石油醚)/V(乙酸乙酯)=5/1]纯化得化合物3a113.7 mg。

用类似的方法合成3b~3n。

3a: 白色固体,产率87%, m.p.160.4~161.3 ℃, 7/1dr;1H NMRδ: 0.93(s, 9H), 2.19(s, 3H), 2.42~2.47(m, 1H), 2.49~2.53(m, 1H), 2.77(s, 3H), 3.79~3.84(m, 2H), 5.93(d,J=9.6 Hz, 1H), 6.93(d,J=5.6 Hz, 1H), 7.02~7.04(m, 1H), 7.23~7.25(m, 1H), 7.38~7.42(m, 2H), 7.44~7.47(m, 2H), 7.85~7.86(m, 1H), 7.97(d,J=5.2 Hz, 2H), 8.07(s, 1H), 8.30(d,J=5.6 Hz, 1H);13C NMRδ: 13.1, 25.9, 26.7, 27.0, 38.3, 52.1, 52.9, 53.6, 80.2, 83.6, 116.9, 117.8, 119.2, 120.2, 122.3, 125.4, 127.1, 127.3, 128.9, 129.4, 129.8, 131.2, 136.3, 138.0, 140.1, 159.9, 160.3, 165.8, 170.4, 175.2, 178.7, 192.0; HR-MS(ESI-TOF)m/z: Calcd for C36H32N3O7ClNa{[M+Na]+}676.1821, found 676.1827。

3b: 白色固体,产率80%, m.p.123.2~124.7 ℃, 8/1dr;1H NMRδ: 0.88(s, 9H), 2.19(s, 3H), 2.34(s, 3H), 2.41~2.45(m, 1H), 2.52~2.56(m, 1H), 2.76(s, 3H), 3.80~3.86(m, 2H), 5.95(d,J=9.6 Hz, 1H), 6.72(d,J=5.6 Hz, 1H), 6.99~7.02(m, 1H), 7.18~7.20(m, 1H), 7.22~7.25(m, 1H), 7.38~7.41(m, 1H), 7.44~7.47(m, 2H), 7.78(s, 1H), 7.84~7.86(m, 1H), 7.96~7.98(m, 2H), 8.20(d,J=5.6 Hz, 1H);13C NMRδ: 13.2, 21.4, 25.8, 26.8, 26.9, 38.4, 52.3, 53.0, 53.5, 80.3, 83.0, 115.5, 117.9, 119.3, 120.3, 122.0, 125.2, 127.2, 127.3, 127.9, 128.8, 129.7, 135.5, 136.1, 138.2, 139.2, 160.2, 160.4, 166.0, 170.5, 175.2, 179.5, 192.4; HR-MS(ESI-TOF)m/z: Calcd for C37H35N3O7Na{[M+Na]+}656.236, found 656.2361。

3c: 白色固体,产率80%, m.p.126.3~127.4 ℃, 11/1dr;1H NMRδ: 0.88(s, 9H), 1.19(s, 3H), 1.20(s, 3H), 2.18(s, 3H), 2.34(s, 3H), 2.41~2.45(m, 1H), 2.50~2.54(m, 1H), 2.75(s, 3H), 2.83~2.88(m, 1H), 3.78~3.83(m, 2H), 5.91(d,J=9.6 Hz, 1H), 6.66(d,J=5.6 Hz, 1H), 7.19(d,J=5.6 Hz, 1H), 7.22~7.24(m, 1H), 7.26~7.29(m, 1H), 7.44~7.46(m, 2H), 7.69(s, 1H), 7.77(s, 1H), 7.97(d,J=5.2 Hz, 2H), 8.19(d,J=5.6 Hz, 1H);13C NMRδ: 13.2, 21.4, 23.9, 25.9, 26.8, 26.9, 33.3, 38.5, 52.2, 53.0, 53.5, 80.4, 83.0, 115.5, 117.8, 119.3, 119.9, 124.4, 125.2, 127.2, 128.0, 128.8, 129.6, 134.8, 135.5, 138.2, 139.2, 142.7, 158.5, 160.4, 166.1, 170.5, 175.2, 179.5, 192.7; HR-MS(ESI-TOF)m/z: Calcd for C40H41N3O7Na{[M+Na]+}698.2837, found 698.2839。

3d: 白色固体,产率89%, m.p.131.4~132.7 ℃, 9/1dr;1H NMRδ: 0.92(s, 9H), 1.20(s, 3H), 1.21(s, 3H), 2.18(s, 3H), 2.45~2.49(m, 2H), 2.76(s, 3H), 2.84~2.89(m, 1H), 3.77~3.82(m, 2H), 5.84(d,J=9.6 Hz, 1H), 6.67(d,J=5.6 Hz, 1H), 7.22~7.25(m, 2H), 7.29~7.31(m, 1H), 7.43~7.46(m, 2H), 7.70(s, 1H), 7.93(d,J=5.2 Hz, 2H), 7.97(d,J=5.6 Hz, 1H), 8.40(s, 1H);13C NMRδ: 13.1, 23.9, 26.0, 26.7, 27.0, 33.3, 38.3, 52.0, 52.8, 53.4, 80.3, 83.4, 116.3, 117.7, 119.5, 119.9, 124.2, 125.4, 125.8, 126.5, 127.8, 128.9, 135.0, 135.1, 138.0, 142.4, 143.0, 158.3, 160.4, 165.9, 170.4, 175.4, 179.0, 192.4; HR-MS(ESI-TOF)m/z: Calcd for C39H38N3O7ClNa{[M+Na]+}718.2290, found 718.2294。

3e: 白色固体,产率83%, m.p.128.3~129.6 ℃, 8/1dr;1H NMRδ: 0.92(s, 9H), 1.20(s, 3H), 1.21(s, 3H), 2.18(s, 3H), 2.45~2.49(m, 2H), 2.76(s, 3H), 2.84~2.89(m, 1H), 3.77~3.82(m, 2H), 5.84(d,J=5.2 Hz, 1H), 6.68(d,J=5.6 Hz, 1H), 7.23~7.25(m, 1H), 7.29~7.31(m, 1H), 7.38~7.40(m, 1H), 7.43~7.46(m, 2H), 7.70(s, 1H), 7.92~7.94(m, 3H), 8.56(s, 1H);13C NMRδ: 13.1, 23.9, 26.0, 26.7, 27.0, 33.3, 38.3, 52.0, 52.8, 53.5, 80.2, 83.4, 117.7, 119.0, 119.5, 119.9, 123.1, 124.2, 125.5, 127.1, 128.2, 128.8, 128.9, 135.0, 138.0, 142.5, 143.0, 158.3, 160.4, 165.9, 170.4, 175.4, 178.9, 192.4; HR-MS(ESI-TOF)m/z: Calcd for C39H38N3O7BrNa{[M+Na]+}762.1785, found 762.1784。

3f: 白色固体,产率75%, m.p.120.6~121.7 ℃, 9/1dr;1H NMRδ: 0.87(s, 9H), 2.18(s, 3H), 2.43~2.52(m, 2H), 2.77(s, 3H), 3.81~3.86(m, 2H), 5.95(d,J=9.6 Hz, 1H), 6.69~6.71(m, 1H), 7.10~7.13(m, 1H), 7.22~7.26(m, 2H), 7.39~7.42(m, 1H), 7.43~7.46(m, 2H), 7.49~7.51(m, 1H), 7.94(d,J=5.2 Hz, 2H), 7.98(d,J=5.2 Hz, 1H), 8.33(d,J=5.2 Hz, 1H);13C NMRδ: 13.1, 25.8, 26.8, 26.9, 38.4, 52.3, 52.9, 53.4, 80.6, 83.2, 112.2 (d,JCF=24.3 Hz), 115.7, 119.5, 119.6, 123.6 (d,JCF=24.0 Hz), 125.4, 125.9, 126.8, 127.8, 128.9, 129.4, 138.0, 141.5, 156.3, 157.6 (d,JCF=241.5 Hz), 160.3, 165.9, 170.5, 175.3, 179.3, 191.6; HR-MS(ESI-TOF)m/z: Calcd for C36H32N3O7FNa{[M+Na]+}660.2116, found 660.2118。

3g: 白色固体,产率84%, m.p.118.0~119.3 ℃, 7/1dr;1H NMRδ: 0.92(s, 9H), 2.18(s, 3H), 2.45~2.50(m, 1H), 2.77(s, 3H), 3.78~3.83(m, 2H), 5.89(d,J=9.6 Hz, 1H), 6.72~6.75(m, 1H), 7.13~7.16(m, 1H), 7.23~7.26(m, 2H), 7.44~7.47(m, 2H), 7.49~7.51(m, 1H), 7.92~7.96(m, 3H), 8.40(s, 1H);13C NMRδ: 13.1, 25.8, 26.7, 27.0, 38.3, 52.1, 52.8, 53.3, 80.5, 83.5, 112.3(d,JCF=22.5 Hz), 116.3, 119.6, 120.8, 123.8(d,JCF=25.5 Hz), 125.6, 125.9, 126.3, 127.9, 128.9, 135.3, 137.9, 142.3, 156.2, 157.8(d,JCF=231.8 Hz), 160.2, 165.8, 170.4, 175.3, 178.9, 191.4; HR-MS(ESI-TOF)m/z: Calcd for C36H31N3O7FClNa{[M+Na]+}694.1727, found 694.1732。

3h: 白色固体,产率82%, m.p.105.3~106.4 ℃, 10/1dr;1H NMRδ: 0.92(s, 9H), 2.18(s, 3H), 2.45~2.49(m, 2H), 2.77(s, 3H), 3.78~3.83(m, 2H), 5.88(d,J=9.6 Hz, 1H), 6.73~6.75(m, 1H), 7.13~7.16(m, 1H), 7.24~7.26(m, 1H), 7.39~7.41(m, 1H), 7.44~7.47(m, 2H), 7.49~7.51(m, 1H), 7.89~7.93(m, 3H), 8.55(s, 1H);13C NMRδ: 13.1, 25.8, 26.7, 27.0, 38.3, 52.1, 52.8, 53.3, 80.4, 83.5, 112.3 (d,JCF=22.5 Hz), 119.1, 119.6, 123.3, 123.8(d,JCF=24.0 Hz), 125.6, 126.8, 128.2, 128.9, 137.9, 142.4, 156.2, 157.3 (d,JCF=246.0 Hz), 160.2, 165.7, 170.4, 175.3, 178.8, 191.4; HR-MS(ESI-TOF)m/z: Calcd for C36H31N3O7FBrNa{[M+Na]+}738.1222, found 738.1222。

3i: 白色固体,产率82%, m.p.139.1~140.4 ℃, 9/1dr;1H NMRδ: 0.87(s, 9H), 2.18(s, 3H), 2.42~2.47(m, 1H), 2.49~2.53(m, 1H), 2.77(s, 3H), 3.82~3.86(m, 2H), 5.96(d,J=9.6 Hz, 1H), 6.69(d,J=6.0 Hz, 1H), 7.23~7.26(m, 2H), 7.33~7.35(m, 1H), 7.39~7.42(m, 1H), 7.44~7.46(m, 2H), 7.80(s, 1H), 7.95(d,J=5.2 Hz, 2H), 7.98(d,J=4.8 Hz, 1H), 8.32(d,J=5.6 Hz, 1H);13C NMRδ: 13.1, 25.8, 26.8, 26.9, 38.3, 52.3, 52.8, 53.4, 80.6, 83.2, 115.7, 119.5, 119.6, 121.0, 125.4, 126.0, 126.6, 126.8, 127.7, 128.9, 129.4, 136.0, 138.0, 141.5, 158.5, 160.2, 165.9, 170.5, 175.2, 179.3, 191.3; HR-MS(ESI-TOF)m/z: Calcd for C36H32N3O7ClNa{[M+Na]+}676.1821, found 676.1827。

3j: 白色固体,产率84%, m.p.128.5~129.4 ℃, 10/1dr;1H NMRδ: 0.93(s, 9H), 2.19(s, 3H), 2.42~2.52(m, 2H), 2.76(s, 3H), 3.78~3.84(m, 2H), 5.95(d,J=9.6 Hz, 1H), 6.70(d,J=6.0 Hz, 1H), 7.23~7.26(m, 1H), 7.35~7.40(m, 2H), 7.45~7.47(m, 2H), 7.81(s, 1H), 7.96(d,J=5.2 Hz, 2H), 8.05(s, 1H), 8.29(d,J=6.0 Hz, 1H);13C NMRδ: 13.1, 25.8, 26.7, 27.0, 38.2, 52.2, 52.9, 53.5, 80.4, 83.7, 117.0, 119.2, 119.6, 121.0, 125.4, 126.6, 127.1, 127.9, 128.9, 129.5, 129.6, 131.3, 136.1, 138.0, 140.0, 158.3, 160.1, 165.6, 170.3, 175.1, 178.5, 191.0; HR-MS(ESI-TOF)m/z: Calcd for C36H31N3O7Cl2Na{[M+Na]+}710.1431, found 710.1436。

3k: 白色固体,产率87%, m.p.127.6~128.7 ℃, 7/1dr;1H NMRδ: 0.92(s, 9H), 2.19(s, 3H), 2.45~2.48(m, 2H), 2.76(s, 3H), 3.80~3.85(m, 2H), 5.92(d,J=9.6 Hz, 1H), 6.70(d,J=6.0 Hz, 1H), 7.10~7.13(m, 1H), 7.24~7.26(m, 1H), 7.35~7.37(m, 1H), 7.44~7.47(m, 2H), 7.81(s, 1H), 7.84~7.86(m, 1H), 7.95(d,J=5.2 Hz, 2H), 8.32~8.34(m, 1H);13C NMRδ: 13.1, 25.8, 26.7, 27.0, 38.2, 52.1, 52.8, 53.6, 80.5, 83.5, 114.6, 114.8, 115.9, 116.0, 117.1, 119.4, 119.5, 121.0, 125.5, 126.6, 127.9, 128.9, 129.7, 136.1, 137.6, 137.9, 158.3, 159.7, 160.2, 161.3, 165.7, 170.3, 175.3, 178.8, 191.0; HR-MS(ESI-TOF)m/z: Calcd for C36H31N3O7FClNa{[M+Na]+}694.1727, found 694.1727。

3l: 白色固体,产率84%, m.p.146.5~147.3 ℃, 7/1dr;1H NMRδ: 0.97(s, 9H), 2.21(s, 3H), 2.46~2.53(m, 2H), 2.78(s, 3H), 3.79~3.86(m, 2H), 5.98(d,J=11.2 Hz, 1H), 6.72(d,J=7.2 Hz, 1H), 7.25~7.28(m, 1H), 7.37~7.40(m, 1H), 7.46~7.50(m, 2H), 7.56~7.58(m, 1H), 7.83(s, 1H), 7.99(d,J=6.4 Hz, 2H), 8.21(s, 1H), 8.25(d,J=7.2 Hz, 1H);13C NMRδ: 13.0, 25.8, 26.5, 27.0, 38.2, 52.3, 52.9, 53.5, 80.4, 83.7, 117.3, 118.9, 119.2, 119.5, 121.1, 125.4, 126.6, 127.9, 128.8, 129.9, 130.0, 132.4, 136.0, 138.0, 140.5, 158.3, 160.0, 165.6, 170.2, 175.1, 178.4, 190.8; HR-MS(ESI-TOF)m/z: Calcd for C36H31N3O7ClBrNa{[M+Na]+}754.0926, found 754.0922。

3m: 白色固体,产率80%, m.p.121.2~122.4 ℃, 10/1dr;1H NMRδ: 0.88(s, 9H), 2.18(s, 3H), 2.34(s, 3H), 2.40~2.44(m, 1H), 2.50~2.54(m, 1H), 2.76(s, 3H), 3.80~3.85(m, 2H), 5.97(d,J=9.6 Hz, 1H), 6.70(d,J=6.0 Hz, 1H), 7.19(d,J=5.6 Hz, 1H), 7.23~7.25(m, 1H), 7.33~7.35(m, 1H), 7.44~7.47(m, 2H), 7.76(s, 1H), 7.80(s, 1H), 7.96(d,J=5.2 Hz, 2H), 8.19(d,J=5.6 Hz, 1H);13C NMRδ: 13.1, 21.4, 25.7, 26.8, 26.9, 38.4, 52.4, 53.0, 53.3, 80.5, 83.1, 115.6, 119.3, 119.6, 121.1, 125.3, 126.5, 127.2, 127.6, 128.9, 129.8, 135.6, 135.9, 138.1, 139.2, 158.6, 160.2, 165.9, 170.4, 175.2, 179.4, 191.3; HR-MS(ESI-TOF)m/z: Calcd for C37H34N3O7ClNa{[M+Na]+}690.1977, found 690.1971。

Scheme 2

3n: 白色固体,产率86%, m.p.112.9~113.4 ℃, 7/1dr;1H NMRδ: 0.83(s, 9H), 2.08(s, 3H), 2.32~2.42(m, 2H), 2.67(s, 3H), 3.69~3.74(m, 2H), 5.81(d,J=9.6 Hz, 1H), 6.63(d,J=6.0 Hz, 1H), 7.14~7.17(m, 1H), 7.26~7.28(m, 1H), 7.30~7.32(m, 1H), 7.35~7.37(m, 2H), 7.72(s, 1H), 7.79~7.83(m, 3H), 8.46(s, 1H);13C NMRδ: 12.1, 24.7, 25.7, 26.0, 37.2, 51.1, 51.7, 52.3, 79.4, 82.5, 118.0, 118.5, 120.0, 122.3, 124.5, 125.6, 125.7, 126.9, 127.2, 127.9, 135.1, 136.9, 141.4, 157.3, 159.1, 164.7, 169.3, 174.2, 177.7, 190.0; HR-MS(ESI-TOF)m/z: Calcd for C36H31N3O7ClBrNa{[M+Na]+}754.0926, found 754.0928。

2 结果与讨论

2.1 合成

以3a的合成为例,研究了催化剂、反应时间和产率对反应的影响,结果见表1。

表1 反应条件的优化

由表1可见,无催化剂存在,反应不能进行,在10 mol%DABCO催化下,3 d内可反应完全,产率达到87%。在其它碱性三级胺类催化剂作用下(DBU, Et3N和DMAP),产率明显降低,且伴有少量副产物生成。

2.2 反应机理

在实验结果和文献[16-20]报道基础上,我们推测了可能的反应机理(Scheme 2):在DABCO的催化作用下,1与2先发生分子间Michael加成,再发生分子内环化反应转化为目标产物3。

合成了14个未见文献报道的吡唑啉酮六氢山酮素骨架拼接氧化吲哚,产率75%~89%,dr值7/1~11/1。化合物骨架含有连续5个立体中心(含两个螺环季碳中心),有望为生物活性筛选提供化合物基础。

猜你喜欢

吡唑吲哚产率
污水厂污泥产率随季节变化研究
芸苔素内酯与吡唑醚菌酯在小麦上的应用技术
吲哚美辛肠溶Eudragit L 100-55聚合物纳米粒的制备
α-烷基苯乙酰胺的合成新方法
CeCl3和CeO2对松木屑的催化热解作用研究
四组分双环化反应合成双吡唑并[3,4-b ]吡啶
HPV16E6与吲哚胺2,3-二氧化酶在宫颈病变组织中的表达
芸苔素内酯与吡唑醚菌酯在玉米上的应用技术
原煤深度解离分步释放浮选试验研究
吲哚骨架7位的羟基化研究